Update on Sclerosing Cholangitis in Critically Ill Patients

Viszeralmedizin: Gastrointestinal Medicine and Surgery

Volumn 31, Issue 3, 2015, Pages 178-184

  Kirchner, Gabriele I ^a   Rümmele, Petra ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cast syndrome; Sclerosing cholangitis in critically ill patients (SC CIP); Secondary sclerosing cholangitis

Indexed keywords

ALKALINE PHOSPHATASE; AMOXICILLIN; BILIRUBIN; CIPROFLOXACIN; CLAVULANIC ACID; GAMMA GLUTAMYLTRANSFERASE; GENTAMICIN; IMIPENEM; URSODEOXYCHOLIC ACID;

ALKALINE PHOSPHATASE BLOOD LEVEL; BILIARY STENT; BILIARY TRACT DRAINAGE; BILIRUBIN BLOOD LEVEL; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); CRITICALLY ILL PATIENT; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INTENSIVE CARE UNIT; LIVER HISTOLOGY; MICROBIOLOGICAL EXAMINATION; REVIEW; SCLEROSING CHOLANGITIS; SYSTEMATIC REVIEW (TOPIC);

EID: 84937423728     PISSN: 16626664     EISSN: 16626672     Source Type: Journal    
DOI: 10.1159/000431031     Document Type: Review

References (31)

1. Gossard AA, Angulo P, Lindor KD: Secondary scleros-ing cholangitis: a comparison to primary sclerosing cholangitis. Am J Gastroenterol 2005;100:1330-1333.
2. Ruemmele P, Hofstaedter F, Gelbmann CM: Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 2009;6:287-295.
3. Nunes G, Blaisdell FW, Margaretten W: Mechanism of hepatic dysfunction following shock and trauma. Arch Surg 1970;100:546-556.
4. Champion HR, Jones RT, Trump BF, Decker R, Wilson S, Miginski M, Gill W: A clinicopathologic study of hepatic dysfunction following shock. Surg Gynecol Obstet 1976;142:657-663.
5. Hartley S, Scott AJ, Spence M: Benign postoperative jaundice complicating severe trauma. N Z Med J 1977; 86:174-178.
6. Scheppach W, Druge G, Wittenberg G, Mueller JG, Gassel AM, Gassel HJ, Richter F: Sclerosing cholangitis and liver cirrhosis after extrabiliary infections: report on three cases. Crit Care Med 2001;29:438-441.
7. Kirchner G, Klingsiek E, Hartl J, Langgartner J, Zuber-Jerger I, Scherer M, Salzberger B, Schlitt H-J, Gelb-mann C: Natural history of sclerosing cholangitis in critically ill patients (SC-CIP): predictors and outcome. J Hepatol 2013;58(suppl 1):S386-S387.
8. Voigtlander T, Negm AA, Schneider AS, Strassburg CP, Manns MP, Wedemeyer J, Lankisch TO: Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome. Endoscopy 2012;44:1055-1058.
9. Benninger J, Grobholz R, Oeztuerk Y, Antoni CH, Hahn EG, Singer MV, Strauss R: Sclerosing cholangitis following severe trauma: description of a remarkable disease entity with emphasis on possible pathophysio-logic mechanisms. World J Gastroenterol 2005;11: 4199-4205.
10. Weig T, Schubert MI, Gruener N, Dolch ME, Frey L, Miller J, Johnson T, Irlbeck M: Abdominal obesity and prolonged prone positioning increase risk of developing sclerosing cholangitis in critically ill patients with influenza A-associated ARDS. Eur J Med Res 2012;17:30.
11. Engler S, Elsing C, Flechtenmacher C, Theilmann L, Stremmel W, Stiehl A: Progressive sclerosing cholangi-tis after septic shock: a new variant of vanishing bile duct disorders. Gut 2003;52:688-693.
12. Gelbmann CM, Rummele P, Wimmer M, Hofstadter F, Gohlmann B, Endlicher E, Kullmann F, Langgartner J, Scholmerich J: Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol 2007;102:1221-1229.
13. Putensen C, Wrigge H, Hering R: The effects of mechanical ventilation on the gut and abdomen. Curr Opin Crit Care 2006;12:160-165.
14. Al-Benna S, Willert J, Steinau HU, Steinstraesser L: Secondary sclerosing cholangitis, following major burn injury. Burns 2010;36:e106-110.
15. Esposito I, Kubisova A, Stiehl A, Kulaksiz H, Schir-macher P: Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis. Virchows Arch 2008;453:339-345.
16. Kulaksiz H, Heuberger D, Engler S, Stiehl A: Poor outcome in progressive sclerosing cholangitis after septic shock. Endoscopy 2008;40:214-218.
17. Kirchner GI, Scherer MN, Obed A, Ruemmele P, Wiest R, Froh M, Loss M, Schlitt HJ, Scholmerich J, Gelbmann CM: Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholan-gitis after liver transplantation. Scand J Gastroenterol 2011;46:471-478.
18. Jaeger C, Mayer G, Henrich R, Gossner L, Rabenstein T, May A, Guenter E, Ell C: Secondary sclerosing chol-angitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment, and follow-up. Endoscopy 2006;38:730-734.
19. Ter Borg PC, van Buuren HR, Depla AC: Bacterial chol-angitis causing secondary sclerosing cholangitis: a case report. BMC Gastroenterol 2002;2:14.
20. Hoffmeister B, Ockenga J, Schachschal G, Suttorp N, Seybold J: Rapid development of secondary sclerosing cholangitis due to vancomycin-resistant enterococci. J Infect 2007;54:e65-68.
21. Lin T, Qu K, Xu X, Tian M, Gao J, Zhang C, Di Y, Zhang Y, Liu C: Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience. Front Med 2014;8:118-126.
22. Batts KP: Ischemic cholangitis. Mayo Clin Proc 1998; 73:380-385.
23. Kobayashi S, Nakanuma Y, Matsui O: Intrahepatic peri-biliary vascular plexus in various hepatobiliary diseases: a histological survey. Hum Pathol 1994;25:940-946.
24. Deltenre P, Valla DC: Ischemic cholangiopathy. J Hepatol 2006;44:806-817.
25. Li MK, Crawford JM: The pathology of cholestasis. Semin Liver Dis 2004;24:21-42.
26. Katsinelos P, Kountouras J, Chatzimavroudis G, Zavos C, Pilpilidis I, Paroutoglou G: Combined endoscopic and ursodeoxycholic acid treatment of biliary cast syndrome in a non-transplant patient. World J Gastro-enterol 2008;14:5223-5225.
27. Strazzabosco M, Spirli C, Okolicsanyi L: Pathophysiol-ogy of the intrahepatic biliary epithelium. J Gastroen-terol Hepatol 2000;15:244-253.
28. Strazzabosco M, Fabris L, Spirli C: Pathophysiology of cholangiopathies. J Clin Gastroenterol 2005;39:S90-S102.
29. Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, Marschall HU, Tsybrovskyy O, Zatloukal K, Denk H, Trauner M: Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 2002;123:1238-1251.
30. Fickert P, Fuchsbichler A, Wagner M, Zollner G, Kaser A, Tilg H, Krause R, Lammert F, Langner C, Zatloukal K, Marschall HU, Denk H, Trauner M: Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastro-enterology 2004;127:261-274.
31. Trauner M, Fickert P, Wagner M: MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin Liver Dis 2007;27:77-98.